13 July 2009 HAL fluorescence cystoscopy: towards a new paradigm in bladder cancer management
Author Affiliations +
Proceedings Volume 7380, Photodynamic Therapy: Back to the Future; 738033 (2009) https://doi.org/10.1117/12.828216
Event: 12th World Congress of the International Photodynamic Association, 2009, Seattle, Washington, United States
Abstract
Hexaminolevulinate fluorescence cystoscopy by the addition of a specific tissue fluorophore enhances the contrast between benign and malignant epithelial (urothelial) cells in the bladder. Improved detection of flat and papillary tumors as confirmed in recent phase III clinical trials allows the urologist to obtain a precise information on the disease extent at the whole surface of the bladder wall. With gaining experience, management of non muscle invasive bladder cancer improves in readiness and accuracy.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Patrice Jichlinski, Patrice Jichlinski, } "HAL fluorescence cystoscopy: towards a new paradigm in bladder cancer management", Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 738033 (13 July 2009); doi: 10.1117/12.828216; https://doi.org/10.1117/12.828216
PROCEEDINGS
8 PAGES


SHARE
Back to Top